Cargando…

A moderate response to plasmapheresis in nephrogenic systemic fibrosis

Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resona...

Descripción completa

Detalles Bibliográficos
Autores principales: Ustuner, Pelin, Kose, Ozlem Karadag, Gulec, A. Tulin, Ozen, Ozlem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981399/
https://www.ncbi.nlm.nih.gov/pubmed/24765365
http://dx.doi.org/10.4081/cp.2011.e124
_version_ 1782311039561367552
author Ustuner, Pelin
Kose, Ozlem Karadag
Gulec, A. Tulin
Ozen, Ozlem
author_facet Ustuner, Pelin
Kose, Ozlem Karadag
Gulec, A. Tulin
Ozen, Ozlem
author_sort Ustuner, Pelin
collection PubMed
description Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resonance imaging in patients with renal insufficiency. Although little is known about the pathogenesis of this disease, the increased expression of transforming growth factor-beta has been demonstrated recently. Herein, we present a case of NSF was partially treated due to a moderate and temporary response to plasmapheresis with no recurrence for 6 months, but returned at the end of 6(th) month.
format Online
Article
Text
id pubmed-3981399
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-39813992014-04-24 A moderate response to plasmapheresis in nephrogenic systemic fibrosis Ustuner, Pelin Kose, Ozlem Karadag Gulec, A. Tulin Ozen, Ozlem Clin Pract Case Report Nephrogenic systemic fibrosis (NSF) is a recently identified idiopathic cutaneous fibrosing disorder that occurs in the setting of renal failure. The disease initially called nephrogenic fibrosing dermopathy is closely linked to exposure to gadolinium-based contrast media used during magnetic resonance imaging in patients with renal insufficiency. Although little is known about the pathogenesis of this disease, the increased expression of transforming growth factor-beta has been demonstrated recently. Herein, we present a case of NSF was partially treated due to a moderate and temporary response to plasmapheresis with no recurrence for 6 months, but returned at the end of 6(th) month. PAGEPress Publications 2011-11-29 /pmc/articles/PMC3981399/ /pubmed/24765365 http://dx.doi.org/10.4081/cp.2011.e124 Text en ©Copyright P. Ustuner et al., 2011 This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Ustuner, Pelin
Kose, Ozlem Karadag
Gulec, A. Tulin
Ozen, Ozlem
A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_full A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_fullStr A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_full_unstemmed A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_short A moderate response to plasmapheresis in nephrogenic systemic fibrosis
title_sort moderate response to plasmapheresis in nephrogenic systemic fibrosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981399/
https://www.ncbi.nlm.nih.gov/pubmed/24765365
http://dx.doi.org/10.4081/cp.2011.e124
work_keys_str_mv AT ustunerpelin amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT koseozlemkaradag amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT gulecatulin amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT ozenozlem amoderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT ustunerpelin moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT koseozlemkaradag moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT gulecatulin moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis
AT ozenozlem moderateresponsetoplasmapheresisinnephrogenicsystemicfibrosis